BlackRock Institutional Trust’s Tempest Therapeutics TPST Stock Holding History

BlackRock Institutional Trust’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.05M	Hold	235	–	–	﹤0.01%	3280
2016 Q3	$4.92M	Buy	235 +18	+8%	+$326K	﹤0.01%	2694
2016 Q2	$3.31M	Buy	217 +21	+11%	+$480K	﹤0.01%	2855
2016 Q1	$5.45M	Sell	196 -2	-1%	-$42.3K	﹤0.01%	2611
2015 Q4	$5.67M	Buy	198 +4	+2%	+$132K	﹤0.01%	2646
2015 Q3	$4.83M	Buy	194 +36	+23%	+$2.42M	﹤0.01%	2740
2015 Q2	$13.4M	Buy	158 +8	+5%	+$733K	﹤0.01%	2212
2015 Q1	$15.2M	Buy	150 +69	+85%	+$9.19M	﹤0.01%	2120
2014 Q4	$10.5M	Buy	81 +34	+72%	+$2.49M	﹤0.01%	2331
2014 Q3	$2.29M	Hold	47	–	–	﹤0.01%	3017
2014 Q2	$1.26M	Buy	47 +11	+31%	+$259K	﹤0.01%	3369
2014 Q1	$933K	Buy	36 +1	+3%	+$28.3K	﹤0.01%	3435
2013 Q4	$930K	Sell	35 -1	-3%	-$27.4K	﹤0.01%	3418
2013 Q3	$1.05M	Buy	36 +7	+24%	+$248K	﹤0.01%	3344
2013 Q2	$1.18M	Buy	+29	New	+$1.09M	﹤0.01%	3285

Other funds holding TPST

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

BlackRock Institutional Trust's TPST Position: Q4 2016 in Review

BlackRock Institutional Trust held its Tempest Therapeutics (TPST) position steady in Q4 2016 at 235 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3280.

BlackRock Institutional Trust first reported a position in TPST in Q2 2013 and has held it in 15 quarters since. The position peaked at $15.2M in Q1 2015. 84 funds tracked by Wall St. Rank hold TPST as of Q4 2016.

BlackRock Institutional Trust held 235 shares of Tempest Therapeutics worth $1.05M as of Q4 2016.
BlackRock Institutional Trust left its Tempest Therapeutics share count unchanged in Q4 2016.
Tempest Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3280 holding.
BlackRock Institutional Trust first reported a position in Tempest Therapeutics in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Tempest Therapeutics position peaked at $15.2M in Q1 2015.
84 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.